Nebido 1000 mg 4ml Ampoule 1pc Im

Nebido should be used with caution in patients with epilepsy and migraine, as the conditions may be aggravated. • hypersensitivity to the active substance or to any of the excipients (listed in section 6.1). Limited data do not suggest the need for a dosage adjustment in elderly patients (see section 4.4).

As with all oily solutions, Testosterone Undecanoate must be injected strictly intramuscularly and very slowly. High-dosed or long-term administration of testosterone occasionally increases the occurrences of water retention and oedema. Serum testosterone levels should be measured before start and during initiation of treatment. Depending on serum testosterone levels and clinical symptoms, the first injection intervalmay be reduced to a minimum of 6 weeks as compared to the recommended range of 10 to 14 weeks for maintenance.

Risks associated with treatment of late-onset hypogonadism

It also performs functions, e.g. in the skin, muscles, skeleton, kidney, liver, bone marrow and CNS. The content of a vial is to be injected intramuscularly immediately after drawing up into the syringe. After removal of the plastic cap (A) do not remove the metal ring (B) or the crimp cap ©. No formal studies have been performed in patients with liver impairment. You will not be prescribed Testosterone Undecanoate if you have ever had a liver tumour (see “Do not use Testosterone Undecanoate”).

7 Effects on ability to drive and use machines

Each ml solution for injection contains 250 mg testosterone undecanoate corresponding to 157.9 mg testosterone. Testosterone and derivatives have been reported to increase the activity of oral anti-coagulants.-Patients receiving oral anti-coagulants require close monitoring,especially at the beginning or end of androgen therapy. Increased monitoring of the prothrombin time, and INR determinations, https://wahmarathi.com/which-anabolic-steroids-can-women-use-to-increase/ are recommended. There is limited experience of the use of Nebido in elderly patients over 65 years of age. However, it should be taken into account that physiologically testosterone serum levels are lower with increasing age.

Medicines

• An increase in serum levels of testosterone above basal values may be seen one day after administration.
• Your doctor will inject Nebido (1 ampoule / vial) very slowly into a muscle.
• Each ml of solution contains 250 mg testosterone undecanoate equivalent to 157.9 mg testosterone.
• Nebido should be permanently withdrawn if symptoms of excessive androgen exposure persist or reappear during treatment with the recommended dosage regimen.

Nebido is not indicated for use in women and must not be used in pregnant or breast-feeding women, see section 4.3. Free thyroid hormone levels remain unchanged, however, and there is no clinical evidence of thyroid dysfunction. Medicines should not be disposed of via wastewater or household waste. This medicine contains 2000 mg benzyl benzoate in each 4 ml ampoule/vial which is equivalent to 500 mg/ml.

The contents of an ampoule / vial are to be injected intramuscularly immediately after opening. (For the ampoule see section 6.6 for instructions on opening the ampoule safely). Your doctor will inject Testosterone Undecanoate (1 vial) very slowly into a muscle.

High-dosed or long-term administration of testosterone occasionally increases the occurrences of water retention and oedema. In patients suffering from severe cardiac, hepatic or renal insufficiency or ischemic heart disease, treatment with testosterone may cause severe complications characterised by oedema with or without congestive cardiac failure. There are no studies undertaken to demonstrate the efficacy and safety of this medicinal product in patients with renal or hepatic impairment.